Elekta

Precision radiotherapy helped Kerry turn a frightening diagnosis into a future filled with confidence, recovery, and getting back to the life she loves. Read more in FOCUS ➡️ bit.ly/4bDJCyY

Leksell Gamma Knife now has CE clearance for medically intractable epilepsy, adding to its U.S. 510(k) clearance. Clinical studies show up to 85% improvement in seizure control for mesial temporal lobe epilepsy – offering new hope for patients with limited options. Learn more: bit.ly/4sJV7fr

Leksell Gamma Knife has treated 2M+ patients and access keeps growing. Nearly 80 Elekta Esprit systems installed in just three years, delivering faster, more personalized & precise care. Protecting quality of life for 100,000+ patients every year. 👉 Learn more: bit.ly/4ssAOmm

We published our Q3 report today. Read the report here ➡️ bit.ly/471Jg3Z

With Elekta Care, you’re supported throughout the entire lifetime of your Leksell Vantage Stereotactic System. From fast remote support to onsite expertise, scheduled performance checks, certified engineers, and technology refresh. Elekta Care keeps every critical component performing at its best. Support that grows with you. Every procedure. Every year. ➡️ bit.ly/4aRnqAW

In FOCUS, read how Lucia regained confidence and joy after precise, surgery-free treatment. bit.ly/4aElWKg

After a frightening meningioma diagnosis, Lucia and her family found hope with Leksell Gamma Knife at IRCCS San Raffaele Hospital in Milan under Professor Pietro Mortini; treated in 2015, the non-invasive radiosurgery spared her open brain surgery and helped her return quickly to the painting, writing and everyday moments she loves. “Gamma Knife would stop the tumor’s growth, and over time it would shrink,” she was told, a reassurance that brought the family long-awaited relief. In FOCUS, read how Lucia regained confidence and joy after precise, surgery-free treatment. bit.ly/4aElWKg

Dr. Neda Haghighi leads the Gamma Knife Service at Peter MacCallum Cancer Center and was key in introducing Leksell Gamma Knife in 2020. This shifted up to 80% of brain cases from linac‑based SRS to Gamma Knife and expanded treatment to a wide range of cranial conditions. In this episode, we explore how Gamma Knife has transformed care at Peter Mac and dive into highlights from Dr. Haghighi’s remarkable career. Welcome to Spilling the RT! ➡️ youtu.be/1rJudwVvH6g

We're curious to know, what’s your clinical profession? Vote below or tell us in the comments! 👇

Roses are red, violets are blue, To all who care for people with cancer, we appreciate you. Your skill, compassion, and steady hands each day Turn precision and physics into hope in a meaningful way. And because we know the MLC has a special place in your heart… Here’s a little Valentine from your favorite beam‑shaping part. Happy Valentine’s Day from Elekta! ❤️🌹 *The video shows an Elekta Agility head (MLC) creating a heart image.

It’s been inspiring to connect with customers and partners at #WHXDubai. From signing ceremonies to hands‑on conversations, it’s been a pleasure showcasing how Elekta is streamlining radiotherapy delivery, elevating the patient experience, and expanding access to high‑quality cancer care worldwide. See you next year! 👋

Receiving a cancer diagnosis is a significant life event. Many people navigate this experience with focus, resilience, and hope. To mark World Cancer Day, we’re sharing the stories of three patients and how their diagnoses shaped their perspectives on life. #WorldCancerDay #UnitedByUnique ➡️ bit.ly/3NDDMWf

Join our Strategic Update digital event for a look at our future direction & innovations in precision radiation therapy—featuring President & CEO Jakob Just‑Bomholt and our leadership team. #Elekta #RadiationTherapy 📅 January 30 at 2 p.m CET 🔗 Register: bit.ly/46cLSey

Today, we announced that Tomas Eliasson is appointed Vice Chair of the Board. Tomas has been a member of the Board since 2023 and brings extensive experience from senior finance and board roles, including former CFO positions at Sandvik, Electrolux and Assa Abloy. Read more in our press release ➡️ bit.ly/4a8SQ6S

Today we announced that our Elekta Evo* CT-Linac has received U.S. FDA 510(k) clearance. This milestone makes the system available to radiation oncology professionals in the United States. Read more in today's press release ➡️ bit.ly/4jIC4ys *Elekta Evo has CE mark and U.S. FDA 510(k) clearance. Not available in all markets.

If you guessed 428,000+, you’re right! Learn more about @Elekta_Fdn and their work at: elektafoundation.com.

Cervical cancer is preventable, but 90% of deaths happen in underserved nations. The @Elekta_Fdn, with Rwanda’s Ministry of Health, is expanding HPV screening and treatment. How many women have been tested for HPV so far? #cervicalcancerawarenessmonth

#RadiationTherapy is steadily advancing, and 2026 is expected to bring meaningful improvements in precision and personalization. What innovation could move the needle most in your clinic in 2026?

From helping clinicians provide the best possible outcomes to celebrating milestones like 2M patients treated with Gamma Knife, we’ve worked to deliver progress for your practices and hope for your patients. Thank you for a great 2025. We look forward to working with you in 2026!